193 related articles for article (PubMed ID: 32772236)
1. Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.
Inoue M; Nakai K; Mitsuiki K
CEN Case Rep; 2021 Feb; 10(1):64-68. PubMed ID: 32772236
[TBL] [Abstract][Full Text] [Related]
2. Nephrogenic diabetes insipidus persisting 57 months after cessation of lithium carbonate therapy: report of a case and review of the literature.
Guirguis AF; Taylor HC
Endocr Pract; 2000; 6(4):324-8. PubMed ID: 11242610
[TBL] [Abstract][Full Text] [Related]
3. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
[TBL] [Abstract][Full Text] [Related]
4. Use of acetazolamide in lithium-induced nephrogenic diabetes insipidus: a case report.
Macau RA; da Silva TN; Silva JR; Ferreira AG; Bravo P
Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29479446
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeutic Option.
Hashikawa R; Yamada H; Fujii T; Ohtsuru S
Am J Case Rep; 2024 Apr; 25():e943244. PubMed ID: 38643357
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
[TBL] [Abstract][Full Text] [Related]
7. [Water, lithium and sodium: watch out for dangerous injuries].
Fayolle M; Souweine JS; Mathieu O; Bargnoux AS; Cristol JP; Badiou S
Ann Biol Clin (Paris); 2020 Aug; 78(4):449-453. PubMed ID: 32618565
[TBL] [Abstract][Full Text] [Related]
8. Lithium-induced nephrogenic diabetes insipidus.
Imam SK; Hasan A; Shahid SK
J Pak Med Assoc; 2005 Mar; 55(3):125-7. PubMed ID: 15852752
[TBL] [Abstract][Full Text] [Related]
9. Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case.
Shen HC; Li JY; Lo YK
Acta Neurol Taiwan; 2007 Dec; 16(4):231-3. PubMed ID: 18220017
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemia and diabetes insipidus in a patient previously treated with lithium.
Khairallah W; Fawaz A; Brown EM; El-Hajj Fuleihan G
Nat Clin Pract Nephrol; 2007 Jul; 3(7):397-404. PubMed ID: 17592473
[TBL] [Abstract][Full Text] [Related]
11. Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature.
Jinnouchi T; Yoshimoto M; Ogino K; Oji T; Hayashi M
Intern Med; 2024 May; 63(10):1399-1404. PubMed ID: 37779064
[TBL] [Abstract][Full Text] [Related]
12. Persistent nephrogenic diabetes insipidus following lithium therapy.
Thompson CJ; France AJ; Baylis PH
Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrinopathies associated with lithium therapy.
Dalan R; Leow MK; Jong M
Endocr Pract; 2007; 13(7):758-63. PubMed ID: 18194933
[TBL] [Abstract][Full Text] [Related]
14. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
[TBL] [Abstract][Full Text] [Related]
15. Lithium-induced nephrogenic diabetes insipidus.
Stone KA
J Am Board Fam Pract; 1999; 12(1):43-7. PubMed ID: 10050642
[TBL] [Abstract][Full Text] [Related]
16. Secondary oxalosis induced by xylitol concurrent with lithium-induced nephrogenic diabetes insipidus: a case report.
Takayasu S; Kamba A; Yoshida K; Terui K; Watanuki Y; Ishigame N; Mizushiri S; Tomita T; Nakamura K; Yasui-Furukori N; Daimon M
BMC Nephrol; 2020 May; 21(1):157. PubMed ID: 32357847
[TBL] [Abstract][Full Text] [Related]
17. What an endocrinologist should know for patients receiving lithium therapy.
Haissaguerre M; Vantyghem MC
Ann Endocrinol (Paris); 2022 Aug; 83(4):219-225. PubMed ID: 35074396
[TBL] [Abstract][Full Text] [Related]
18. Lithium-associated primary hyperparathyroidism complicated by nephrogenic diabetes insipidus.
Aksakal N; Erçetin C; Özçınar B; Aral F; Erbil Y
Ulus Cerrahi Derg; 2015; 31(3):166-9. PubMed ID: 26504422
[TBL] [Abstract][Full Text] [Related]
19. [Lithium and its relation with the epithelial sodium channel and aquaporin-2].
Galizia L; Marino GI; Kotsias BA
Medicina (B Aires); 2012; 72(2):171-5. PubMed ID: 22522861
[TBL] [Abstract][Full Text] [Related]
20. [Nephrogenic diabetes insipidus during lithium acute intoxication].
Abodo J; Seux V; Koffi-Dago P; Dalco O; Renaud-Lévy O; Tassy S; Million M; Lokrou A; Soubeyrand J; Retornaz F
Ann Endocrinol (Paris); 2007 Dec; 68(6):467-9. PubMed ID: 18031708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
